Center for Immunization Research, Johns Hopkins School of Public Health

Baltimore, Maryland 21205

0 studies enrolling now · 13 studies all time

What they study most

Dengue, Dengue Fever, Dengue Hemorrhagic Fever, Dengue Shock Syndrome, Zika Virus

Studies at this site

• Evaluation of the Protective Efficacy of TV003 or Previous Zika Infection Against Infection With ZIKV-SJRP Challenge Compared to DENV and ZIKV-naïve Controls Against Infection With ZIKV-SJRP Challenge — Completed
• Evaluating the Safety and Immunogenicity of a Tetravalent Dengue Vaccine (TetraVax-DV) TV005 in Flavivirus-Naive Adults 50 to 70 Years of Age — Completed
• Evaluating the Safety and Protective Efficacy of a Single Dose of the Live Attenuated Tetravalent Dengue Vaccine TV005 to Protect Against Infection With rDEN3Δ30 — Completed
• Evaluating the Clinical and Immune Response to Two Dengue Virus Vaccines in Healthy Adults — Completed
• Evaluation of the Safety and Efficacy of a Single Dose of a Dengue Vaccine (TV005) in Healthy Adults — Completed
• Evaluating the Safety, Tolerability, and Immunogenicity of a Tetravalent Dengue Vaccine (V180) in Healthy Adults Who Previously Received a Live-Attenuated Tetravalent Vaccine (TV003 or TV005) — Completed
• Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus Vaccine — Completed
• Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus Vaccine — Completed
• Evaluation of the Safety and Immune Response of Five Admixtures of a Tetravalent Dengue Virus Vaccine — Completed
• Safety of and Immune Response to DEN4 Vaccine Component Candidate for Dengue Virus — Completed
• Safety of and Immune Response to a Dengue Virus Vaccine (rDEN4delta30-200,201) in Healthy Adults — Completed
• Safety of and Immune Response of a 2-dose Regimen of rDEN1delta30 Dengue Virus Vaccine — Completed
• Safety of and Immune Response to a Dengue Virus Vaccine (rDEN1delta30) in Healthy Adults — Completed